| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | John Kouvaris | |
| Vassilios Kouloulias | |||
| Georgios V Koukourakis | |||
| Georgios A Zacharias | |||
| Haralabos Zabatis | |||
| Michael J Koukourakis | |||
| P2860 | cites work | Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial | Q44253349 |
| Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial | Q44265656 | ||
| Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. | Q44396415 | ||
| Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial | Q44457418 | ||
| Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy | Q44525923 | ||
| Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer | Q44572711 | ||
| Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma | Q44723860 | ||
| Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. | Q44764054 | ||
| A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer | Q44853139 | ||
| Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer | Q44910538 | ||
| Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study | Q44936609 | ||
| Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer | Q46507603 | ||
| Results of a phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer | Q46522138 | ||
| Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study | Q46640577 | ||
| Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study | Q46747924 | ||
| Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study | Q46799677 | ||
| Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer | Q46930586 | ||
| Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. | Q51783229 | ||
| Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer | Q59647361 | ||
| A Phase II Study of Preoperative Capecitabine and Radiation Therapy in Patients With Rectal Cancer | Q60192965 | ||
| Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer | Q70478710 | ||
| Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine | Q70529566 | ||
| Relationship between fluorouracil systemic exposure and tumor response and patient survival | Q72504290 | ||
| Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study | Q73544195 | ||
| Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine) | Q77087512 | ||
| Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma | Q79396495 | ||
| A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer | Q79721051 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue | Q27863454 | ||
| Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy | Q30433652 | ||
| Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study | Q33358845 | ||
| Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase | Q33376459 | ||
| Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine | Q33502454 | ||
| Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer | Q33855276 | ||
| XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer | Q33978749 | ||
| Capecitabine: preclinical pharmacology studies | Q34084259 | ||
| Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. | Q34465823 | ||
| Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study | Q34514696 | ||
| Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study | Q34519158 | ||
| Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy. | Q34520221 | ||
| Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results | Q34524041 | ||
| Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. | Q34559198 | ||
| Chemotherapy with preoperative radiotherapy in rectal cancer | Q34570877 | ||
| Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. | Q34571372 | ||
| New systemic frontline treatment for metastatic colorectal carcinoma | Q35741932 | ||
| Systemic chemotherapy for pancreatic cancer | Q35746026 | ||
| Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial | Q36147847 | ||
| Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons | Q36356364 | ||
| A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer | Q36610100 | ||
| Capecitabine in the treatment of metastatic renal cell carcinoma | Q36621825 | ||
| Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines. | Q36644465 | ||
| A phase II trial of capecitabine (Xeloda®) in recurrent ovarian cancer | Q36671560 | ||
| Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial | Q36694859 | ||
| Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer | Q36697132 | ||
| Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer | Q37323827 | ||
| Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis | Q38283244 | ||
| Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. | Q43654175 | ||
| Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer | Q43791689 | ||
| Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients | Q43824330 | ||
| Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer | Q43843462 | ||
| Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer | Q43937160 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| capecitabine | Q420207 | ||
| deoxycytidine | Q422504 | ||
| neoplasm | Q1216998 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1897-1922 | |
| P577 | publication date | 2008-08-27 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review | |
| P478 | volume | 13 |
| Q46865578 | A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. |
| Q34658293 | Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study |
| Q34542467 | Clinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials |
| Q36598736 | Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer |
| Q39064132 | Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers |
| Q97537783 | Effective Oral Administration of Antitumorigenic Nanoformulated Titanium Complex |
| Q37346140 | Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT. |
| Q92823869 | Glycosyl ortho-(1-phenylvinyl)benzoates versatile glycosyl donors for highly efficient synthesis of both O-glycosides and nucleosides |
| Q38803038 | Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics |
| Q34337609 | Prodrugs: a challenge for the drug development |
| Q33421880 | Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial |
| Q39735268 | Regioselective metalation of 6-methylpurines: synthesis of fluoromethyl purines and related nucleosides for suicide gene therapy of cancer |
Search more.